GlassScriptPhysician profile
Glenn J Williams
NPI 1598756835
$1,416.95
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,089 · 2020: $113 · 2021: $66.70 · 2022: $148.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $842.31 | 2019 | |
| Glaxosmithkline, LLC. | $246.55 | 2019-2022 | |
| Genentech USA, INC. | $74.73 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $41.22 | 2021-2022 | |
| Ethicon INC. | $39.36 | 2020 | |
| Pfizer INC. | $34.18 | 2019-2020 | |
| Grifols USA, LLC | $31.36 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.59 | 2022 | |
| Mylan Specialty L.P. | $19.58 | 2019 | |
| Harmony Biosciences LLC | $17.47 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.14 | 2020 | |
| Abbvie INC. | $12.16 | 2021 | |
| Allergan, INC. | $12.06 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.24 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.